As of Mar 27
| -0.04 / -5.63%|
The 1 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.90, with a high estimate of 1.90 and a low estimate of 1.90. The median estimate represents a +183.58% increase from the last price of 0.67.
The current consensus among 1 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.